Drug-Releasing Microchip Implants

A pharma company with generic drugs meets michrochip and biotech in a marriage of implantable devices that are shockingly close to the finish line of commercialization.
Deals were made. Money exchanged. Development in process – this is actually going to happen.

Is this the next phase of The Singularity? The complete bypassing of pills, injections – things that one actively chooses and takes – to a passive acceptance of remote controlled wireless chips quietly and somehow pumping substance for up to 16 years? Or is it more public relations for the long-time push for the coming ”brain chip”?

But first to roll out will probably be the wirelessly controlled birth-control implanted device backed by the Bill and Melinda Gates Foundation. (ANYONE WHO AGREES TO THIS ONE IS A CANDIDATE FOR EXTERMINATION FOR SURE)Rob Matheson of TechSwarm reports:

…Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant to commercialize its wirelessly controlled, implantable, microchip-based devices that store and release drugs inside the body over many years. 

Invented by Microchips Biotech co-founders Michael Cima, the David H. Koch Professor of Engineering, and Robert Langer, the David H. Koch Institute Professor, the microchips consist of hundreds of pinhead-sized reservoirs, each capped with a metal membrane, that store tiny doses of therapeutics or chemicals. An electric current delivered by the device removes the membrane, releasing a single dose… (For those who are not aware, the chemtrails as well as water and some foods contain nano-particles that have their own ‘brains’. They search the body for their counterparts and connect together. Some produce morgellons – a horrendous man made bioweapon that causes misery to the point of committing suicide. These electric current chips can receive and obey ‘kill’ orders. Research these for yourself if you don’t believe this.)

[...] 

Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world’s largest producer of generic drugs, to treat specific diseases with licensing potential for other products. Teva paid $35 million up front with additional milestone payments as the device goes through clinical trials before it hits the shelves. (DON’T AGREE TO ACCEPT THESE CHIPS!  THEY WILL BE USED AGAINST YOU!)

http://www.activistpost.com/2015/06/deal-reached-wireless-remote-drug.html